MAPK4 inhibits the early aberrant activation of B cells in rheumatoid arthritis by promoting the IRF4-SHIP1 signaling pathway
Abstract The involvement of B lymphocytes in the pathogenesis of rheumatoid arthritis (RA) is well-established, with their early and aberrant activation being a crucial factor. However, the mechanisms underlying this abnormal activation in RA remain incompletely understood. In this study, we identif...
Saved in:
Main Authors: | Pei Huang, Guangli Yang, Pingping Zhang, Yin Zhu, Yaning Guan, Jian Sun, Qian Li, Yang An, Xiaoqi Shi, Juanjuan Zhao, Chaohong Liu, Zhixu He, Yan Chen, Zuochen Du |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2025-01-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-025-07352-2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MBD2 Regulates Th17 Cell Differentiation and Experimental Severe Asthma by Affecting IRF4 Expression
by: Aijun Jia, et al.
Published: (2017-01-01) -
Adiponectin and rheumatoid arthritis
by: Beuy Joob, et al.
Published: (2019-01-01) -
Distinguishing rheumatoid arthritis from psoriatic arthritis
by: Joseph F Merola, et al.
Published: (2018-08-01) -
Cervical Myelopathy in Rheumatoid Arthritis
by: N. Mukerji, et al.
Published: (2011-01-01) -
Efficacy and Safety of Iguratimod for the Treatment of Rheumatoid Arthritis
by: Jiangtao Li, et al.
Published: (2013-01-01)